The ensuing findings unequivocally underscore that escalated expression levels of SLC7A11 correlate conspicuously with compromised overall survival (OS), a abbreviated progression-free interval (PFI), and constrained disease-specific survival (DSS) within the subset afflicted by ccRCC. The gene discussed is SLC7A11; the disease is nonpapillary renal cell carcinoma.